1. Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)

   • Hitoshi Tsuda
   • General Rule Committee of the Japanese Breast Cancer Society

   Special Article 09 March 2020 Pages: 309 - 321

2. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

   • Tatsunori Shimoi
   • Shigenori E. Nagai
   • Tatsuya Toyama

   Special Article Open access 02 April 2020 Pages: 322 - 331

3. The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established?

   • Toshimi Takano

   Special Feature 27 April 2020 Pages: 332 - 333

4. Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition

   • Tetsuhiro Yoshinami
   • Kei Koizumi
   • Hiroji Iwata

   Special Feature 08 January 2020 Pages: 334 - 339

   

5. First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis

   • Tatsunori Shimoi
   • Yasuaki Sagara
   • Hiroji Iwata

   Special Feature Open access 11 February 2020 Pages: 340 - 346

   

6. Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

   • Minoru Miyashita
   • Masaya Hattori
   • Hiroji Iwata

   Special Feature 23 January 2020 Pages: 347 - 354

   

7. DNA damage repair functions and targeted treatment in breast cancer

   • Chenfeng He
   • Kosuke Kawaguchi
   • Masakazu Toi

   Review Article 02 January 2020 Pages: 355 - 362

   

8. BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer

   • Kai Li
   • Wen-ting Pan
   • Jing-wei Zhang

   Original Article 14 November 2019 Pages: 363 - 371

   

9. ¹⁸F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer

   • Honglian Liu
   • Hao Sun
   • Yang He

   Original Article 28 November 2019 Pages: 372 - 380

   

10. Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups

    • Brigid K. Killelea
    • Jeph Herrin
    • Cary P. Gross

    Original Article 02 December 2019 Pages: 381 - 388

    

11. Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

    • Hidetoshi Kawaguchi
    • Norikazu Masuda
    • Shinji Ohno

    Original Article Open access 06 December 2019 Pages: 389 - 398

    

12. First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis

    • Weiting Liao
    • Jiaxing Huang
    • Qiu Li

    Original Article 18 December 2019 Pages: 399 - 404

    

13. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up

    • Satoko Okamoto
    • Shu-Tian Chen
    • Debra M. Ikeda

    Original Article 14 December 2019 Pages: 405 - 414

    

14. Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells

    • Emi Kishino
    • Ryohei Ogata
    • Junichi Kurebayashi

    Original Article 10 December 2019 Pages: 415 - 425

    

15. Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers

    • L. S. E. van Egdom
    • M. A. de Kock
    • L. B. Koppert

    Original Article Open access 12 December 2019 Pages: 426 - 434

    

16. Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction

    • F. C. J. Reinders
    • D. A. Young-Afat
    • W. Maarse

    Original Article 19 December 2019 Pages: 435 - 444

    

17. Growth pattern can be used as a new characteristic to predict malignancy in breast cancer

    • Bin Wang
    • Lizhe Zhu
    • Ke Wang

    Original Article Open access 03 January 2020 Pages: 445 - 455

    

18. Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population

    • Yuk-Kwan Chang
    • Michael Co
    • Ava Kwong

    Original Article 08 January 2020 Pages: 456 - 463

    

19. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing

    • Ling Zhang
    • Xiaojuan Zhang
    • Jing Liu

    Original Article 09 January 2020 Pages: 464 - 476

    

20. Comorbidity and polypharmacy in patients with breast cancer

    • Ulaş Serkan Topaloğlu
    • Ersin Özaslan

    Original Article 02 January 2020 Pages: 477 - 482

21. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer

    • Tolga Acun
    • Kerem Mert Senses

    Original Article 04 January 2020 Pages: 483 - 489

    

22. Microsatellite instability in Japanese female patients with triple-negative breast cancer

    • Kanako Kurata
    • Makoto Kubo
    • Masafumi Nakamura

    Original Article Open access 06 January 2020 Pages: 490 - 498

    

23. Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient

    • Yoko Ohishi
    • Aki Mitsuda
    • Toshiharu Minabe

    Case Report Open access 24 February 2020 Pages: 499 - 504

    

24. Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer

    • Stéphanie Blockhuys
    • Donita C. Brady
    • Pernilla Wittung-Stafshede

    Rapid Communication Open access 02 January 2020 Pages: 505 - 509